Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.

Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.

IL-1 is an important mediator of inflammation and a major cause of tissue damage in rheumatoid arthritis (RA). Therapeutic administration of recombinant IL-1 receptor antagonist (IL-1Ra) is efficacious in reducing clinical symptoms of disease, but suffers from several drawbacks, including the need f...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Spohn, G, Keller, I, Beck, M, Grest, P, Jennings, G, Bachmann, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles.
de réir: Spohn, G, et al.
Foilsithe / Cruthaithe: (2005)

Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
de réir: Röhn, T, et al.
Foilsithe / Cruthaithe: (2006)

A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis.
de réir: Spohn, G, et al.
Foilsithe / Cruthaithe: (2007)

The coming of age of virus-like particle vaccines.
de réir: Jennings, G, et al.
Foilsithe / Cruthaithe: (2008)

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
de réir: Brune, K, et al.
Foilsithe / Cruthaithe: (2016)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
de réir: Spohn, G, et al.
Foilsithe / Cruthaithe: (2010)

Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKL.
de réir: Spohn, G, et al.
Foilsithe / Cruthaithe: (2007)

A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain.
de réir: Röhn, T, et al.
Foilsithe / Cruthaithe: (2011)

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.
de réir: Engeroff, P, et al.
Foilsithe / Cruthaithe: (2017)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
de réir: Beck Markus, et al.
Foilsithe / Cruthaithe: (2010-07-01)

Bacterially produced recombinant influenza vaccines based on virus-like particles
de réir: Jegerlehner, A, et al.
Foilsithe / Cruthaithe: (2013)

Virus-like particles as a modular system for novel vaccines.
de réir: Lechner, F, et al.
Foilsithe / Cruthaithe: (2002)

A Novel Recombinant Virus-Like Particles Displaying B and T Cell Epitopes of Japanese Encephalitis Virus Offers Protective Immunity in Mice and Guinea Pigs
de réir: Muhammad Naveed Anwar, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system
de réir: Mohsen, M, et al.
Foilsithe / Cruthaithe: (2018)

M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity
de réir: Furui Zhang, et al.
Foilsithe / Cruthaithe: (2025-01-01)

On the role of the innate immunity in autoimmune disease.
de réir: Bachmann, M, et al.
Foilsithe / Cruthaithe: (2001)

Versatile virus-like particle carrier for epitope based vaccines
de réir: Tissot, A, et al.
Foilsithe / Cruthaithe: (2010)

Blocking IL-1α but not IL-1β increases susceptibility to chronic Mycobacterium tuberculosis infection in mice.
de réir: Guler, R, et al.
Foilsithe / Cruthaithe: (2011)

Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis.
de réir: Sonderegger, I, et al.
Foilsithe / Cruthaithe: (2006)

Broad protective immune responses elicited by bacterium-like particle-based intranasal pneumococcal particle vaccine displaying PspA2 and PspA4 fragments
de réir: Jingcai Lu, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice
de réir: Shengnan Zhang, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.
de réir: Schmitz, N, et al.
Foilsithe / Cruthaithe: (2009)

Virus-like particle display of HER2 induces potent anti-cancer responses
de réir: Arianna Palladini, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
de réir: Gilbert, S, et al.
Foilsithe / Cruthaithe: (2017)

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
de réir: Kündig, T, et al.
Foilsithe / Cruthaithe: (2006)

Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis
de réir: Reka Kugyelka, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Virus-like Particle Display of the α‑Gal Carbohydrate for Vaccination against Leishmania Infection
de réir: Anna Paula V. Moura, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
de réir: Ming Yang, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis
de réir: Li Rong, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Bacterially produced recombinant influenza vaccines based on virus-like particles.
de réir: Andrea Jegerlehner, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
de réir: Peabody David S, et al.
Foilsithe / Cruthaithe: (2011-05-01)

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles
de réir: Xinyue Chang, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
de réir: Klimek, L, et al.
Foilsithe / Cruthaithe: (2014)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
de réir: Mona O. Mohsen, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes
de réir: Gunther Spohn, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.
de réir: Karen A O Martins, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Immunization with GP1 but Not Core-like Particles Displaying Isolated Receptor-Binding Epitopes Elicits Virus-Neutralizing Antibodies against Junín Virus
de réir: Gleyder Roman-Sosa, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Special Issue “Virus-Like Particle Vaccines”
de réir: Monique Vogel, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
de réir: Hyeon-Jeong Go, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Genetic Associations Between IL-6 and the Development of Autoimmune Arthritis Are Gender-Specific
de réir: Jianqiao Hong, et al.
Foilsithe / Cruthaithe: (2021-09-01)